These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6689366)

  • 1. Synthesis and some pharmacological properties of a conformationally restricted imipramine analogue.
    Grol CJ; Westenberg G; Hazelhoff B; De Vries J
    Pharm Weekbl Sci; 1983 Dec; 5(6):329-32. PubMed ID: 6689366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
    Pawlowski L; Nowak G; Górka Z; Mazela H
    Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted tricyclic antidepressants. 1. Octahydrodibenzazepinonaphthyridines as rigid imipramine analogues.
    Martin AR; Paradkar VM; Peng GW; Speth RC; Yamamura HI; Horn AS
    J Med Chem; 1980 Aug; 23(8):865-73. PubMed ID: 6249933
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of imipramine-imipraminium in mice. To elucidate central or peripheral origin of effects of imipramine.
    Frances H; Simon P
    Neuropharmacology; 1985 Jul; 24(7):659-63. PubMed ID: 4022276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of heart 3H-norepinephrine up-take by 4-phenyl-1-aminotetralines: implications for the active conformation of imipramine-like drugs.
    Sarges R; Koe BK; Weissman A; Schaefer JP
    J Pharmacol Exp Ther; 1974 Dec; 191(3):393-402. PubMed ID: 4427286
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies.
    Meignen J; Grognet A; Deniard MJ; Dalphrase F; Roux E; DeFeudis FV
    Gen Pharmacol; 1982; 13(5):381-91. PubMed ID: 6890919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.
    Wachtel H
    Neuropharmacology; 1983 Mar; 22(3):267-72. PubMed ID: 6302550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the nature of antagonism of the reserpine-induced hypothermia by imipramine.
    Francès H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):303-7. PubMed ID: 2891045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by tricyclic antidepressants of reserpine-induced hypothermia in mice. Involvement of postsynaptic alpha 2-adrenoceptors.
    Przegaliński E; Siwanowicz J; Baran L; Bigajska K
    Pol J Pharmacol Pharm; 1983; 35(4):309-17. PubMed ID: 6320144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
    Sofia RD; Kubena RK; Barry H
    Psychopharmacologia; 1973 Jul; 31(2):121-30. PubMed ID: 4722206
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
    Pálosi E; Mészáros C; Szporny L
    Arzneimittelforschung; 1969 Nov; 19(11):1882-7. PubMed ID: 5395660
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cocaine and imipramine on tyramine-induced release of noradrenaline-3H from the rat vas deferens in vitro.
    Barnett A; Staub M; Symchowicz S
    Br J Pharmacol; 1969 May; 36(1):79-84. PubMed ID: 5768130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain desipramine level in relation to the anti-reserpine acitivity of imipramine.
    Jori A; Bernardi D
    J Pharm Pharmacol; 1968 Dec; 20(12):955-6. PubMed ID: 4388340
    [No Abstract]   [Full Text] [Related]  

  • 16. THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE.
    QUINTON RM
    Br J Pharmacol Chemother; 1963 Aug; 21(1):51-66. PubMed ID: 14066151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of 9-gamma-methylaminopropyl-9,10-dihydro-9,10-methanoanthracene-HCl (ID-9206-HCl), a new potent antidepressant.
    Fukushima H; Nakamura M; Yamamoto H
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):163-76. PubMed ID: 931463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of aminazine and haloperidol on the antireserpine action of damilene (amitriptyline) and imipramine].
    Vinogradov VV
    Farmakol Toksikol; 1968; 31(1):8-10. PubMed ID: 5675359
    [No Abstract]   [Full Text] [Related]  

  • 19. Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine.
    Swann AC
    Neuropharmacology; 1988 Mar; 27(3):261-7. PubMed ID: 2836750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity.
    Balsamo A; Lapucci A; Macchia M; Martinelli A; Nencetti S; Rossello A; Cristina T
    Farmaco; 1994 Feb; 49(2):77-82. PubMed ID: 8003184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.